A disease-based comparison of liver transplantation outcomes

Brian Mailey, Brian Buchberg, Christie Prendergast, Avo Artinyan, Joshua Khalili, Nicelio Sanchez-Luege, Steven D Colquhoun, Joseph Kim

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

An increasing demand for transplant donor organs has made optimal allocation of resources a priority. Our objective was to evaluate outcomes for orthotopic liver transplantation (OLT) performed in the United States. A query of the United Network for Organ Sharing registry between 1988 and 2007 was performed for patients who underwent OLT for all etiologies. Patients were stratified by pathology necessitating OLT and clinical and pathologic factors were compared. Multivariate Cox-regression analysis was used to assess the association of pathology with survival. Of 61,823 patients, 33 per cent (n = 20,305) of OLTs were secondary to hepatitis C virus, 21 per cent autoimmune disease, 17 per cent alcohol-induced injury, 11 per cent cryptogenic cirrhosis, 8 per cent hepatocellular carcinoma (HCC), 6 per cent hepatitis B virus, and 4 per cent metabolic disease. Patients with autoimmune disease and HCC demonstrated the best and worst survival, respectively, after OLT (median survival 16.0 vs 6.4 yrs, respectively, P < 0.001). By multivariate analysis, OLT for HCC was significantly associated with poorer overall survival (hazard ratio [HR] 2.19, 95% confidence interval [CI]: 2.02-2.37, P < 0.001). Our results indicate that outcomes for liver transplantation vary by primary hepatic pathology with HCC patients having the poorest overall survival. To optimize organ allocation for all patients with end-stage liver disease, a better understanding of poor survival for HCC is necessary.

Original languageEnglish (US)
Pages (from-to)901-908
Number of pages8
JournalAmerican Surgeon
Volume75
Issue number10
StatePublished - Oct 1 2009
Externally publishedYes

Fingerprint

Liver Transplantation
Hepatocellular Carcinoma
Survival
Pathology
Autoimmune Diseases
End Stage Liver Disease
Resource Allocation
Metabolic Diseases
Hepatitis B virus
Hepacivirus
Registries
Multivariate Analysis
Regression Analysis
Alcohols
Tissue Donors
Confidence Intervals
Liver
Wounds and Injuries

ASJC Scopus subject areas

  • Surgery

Cite this

Mailey, B., Buchberg, B., Prendergast, C., Artinyan, A., Khalili, J., Sanchez-Luege, N., ... Kim, J. (2009). A disease-based comparison of liver transplantation outcomes. American Surgeon, 75(10), 901-908.

A disease-based comparison of liver transplantation outcomes. / Mailey, Brian; Buchberg, Brian; Prendergast, Christie; Artinyan, Avo; Khalili, Joshua; Sanchez-Luege, Nicelio; Colquhoun, Steven D; Kim, Joseph.

In: American Surgeon, Vol. 75, No. 10, 01.10.2009, p. 901-908.

Research output: Contribution to journalArticle

Mailey, B, Buchberg, B, Prendergast, C, Artinyan, A, Khalili, J, Sanchez-Luege, N, Colquhoun, SD & Kim, J 2009, 'A disease-based comparison of liver transplantation outcomes', American Surgeon, vol. 75, no. 10, pp. 901-908.
Mailey B, Buchberg B, Prendergast C, Artinyan A, Khalili J, Sanchez-Luege N et al. A disease-based comparison of liver transplantation outcomes. American Surgeon. 2009 Oct 1;75(10):901-908.
Mailey, Brian ; Buchberg, Brian ; Prendergast, Christie ; Artinyan, Avo ; Khalili, Joshua ; Sanchez-Luege, Nicelio ; Colquhoun, Steven D ; Kim, Joseph. / A disease-based comparison of liver transplantation outcomes. In: American Surgeon. 2009 ; Vol. 75, No. 10. pp. 901-908.
@article{124ea4415bd142c095ddc6115303f671,
title = "A disease-based comparison of liver transplantation outcomes",
abstract = "An increasing demand for transplant donor organs has made optimal allocation of resources a priority. Our objective was to evaluate outcomes for orthotopic liver transplantation (OLT) performed in the United States. A query of the United Network for Organ Sharing registry between 1988 and 2007 was performed for patients who underwent OLT for all etiologies. Patients were stratified by pathology necessitating OLT and clinical and pathologic factors were compared. Multivariate Cox-regression analysis was used to assess the association of pathology with survival. Of 61,823 patients, 33 per cent (n = 20,305) of OLTs were secondary to hepatitis C virus, 21 per cent autoimmune disease, 17 per cent alcohol-induced injury, 11 per cent cryptogenic cirrhosis, 8 per cent hepatocellular carcinoma (HCC), 6 per cent hepatitis B virus, and 4 per cent metabolic disease. Patients with autoimmune disease and HCC demonstrated the best and worst survival, respectively, after OLT (median survival 16.0 vs 6.4 yrs, respectively, P < 0.001). By multivariate analysis, OLT for HCC was significantly associated with poorer overall survival (hazard ratio [HR] 2.19, 95{\%} confidence interval [CI]: 2.02-2.37, P < 0.001). Our results indicate that outcomes for liver transplantation vary by primary hepatic pathology with HCC patients having the poorest overall survival. To optimize organ allocation for all patients with end-stage liver disease, a better understanding of poor survival for HCC is necessary.",
author = "Brian Mailey and Brian Buchberg and Christie Prendergast and Avo Artinyan and Joshua Khalili and Nicelio Sanchez-Luege and Colquhoun, {Steven D} and Joseph Kim",
year = "2009",
month = "10",
day = "1",
language = "English (US)",
volume = "75",
pages = "901--908",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "10",

}

TY - JOUR

T1 - A disease-based comparison of liver transplantation outcomes

AU - Mailey, Brian

AU - Buchberg, Brian

AU - Prendergast, Christie

AU - Artinyan, Avo

AU - Khalili, Joshua

AU - Sanchez-Luege, Nicelio

AU - Colquhoun, Steven D

AU - Kim, Joseph

PY - 2009/10/1

Y1 - 2009/10/1

N2 - An increasing demand for transplant donor organs has made optimal allocation of resources a priority. Our objective was to evaluate outcomes for orthotopic liver transplantation (OLT) performed in the United States. A query of the United Network for Organ Sharing registry between 1988 and 2007 was performed for patients who underwent OLT for all etiologies. Patients were stratified by pathology necessitating OLT and clinical and pathologic factors were compared. Multivariate Cox-regression analysis was used to assess the association of pathology with survival. Of 61,823 patients, 33 per cent (n = 20,305) of OLTs were secondary to hepatitis C virus, 21 per cent autoimmune disease, 17 per cent alcohol-induced injury, 11 per cent cryptogenic cirrhosis, 8 per cent hepatocellular carcinoma (HCC), 6 per cent hepatitis B virus, and 4 per cent metabolic disease. Patients with autoimmune disease and HCC demonstrated the best and worst survival, respectively, after OLT (median survival 16.0 vs 6.4 yrs, respectively, P < 0.001). By multivariate analysis, OLT for HCC was significantly associated with poorer overall survival (hazard ratio [HR] 2.19, 95% confidence interval [CI]: 2.02-2.37, P < 0.001). Our results indicate that outcomes for liver transplantation vary by primary hepatic pathology with HCC patients having the poorest overall survival. To optimize organ allocation for all patients with end-stage liver disease, a better understanding of poor survival for HCC is necessary.

AB - An increasing demand for transplant donor organs has made optimal allocation of resources a priority. Our objective was to evaluate outcomes for orthotopic liver transplantation (OLT) performed in the United States. A query of the United Network for Organ Sharing registry between 1988 and 2007 was performed for patients who underwent OLT for all etiologies. Patients were stratified by pathology necessitating OLT and clinical and pathologic factors were compared. Multivariate Cox-regression analysis was used to assess the association of pathology with survival. Of 61,823 patients, 33 per cent (n = 20,305) of OLTs were secondary to hepatitis C virus, 21 per cent autoimmune disease, 17 per cent alcohol-induced injury, 11 per cent cryptogenic cirrhosis, 8 per cent hepatocellular carcinoma (HCC), 6 per cent hepatitis B virus, and 4 per cent metabolic disease. Patients with autoimmune disease and HCC demonstrated the best and worst survival, respectively, after OLT (median survival 16.0 vs 6.4 yrs, respectively, P < 0.001). By multivariate analysis, OLT for HCC was significantly associated with poorer overall survival (hazard ratio [HR] 2.19, 95% confidence interval [CI]: 2.02-2.37, P < 0.001). Our results indicate that outcomes for liver transplantation vary by primary hepatic pathology with HCC patients having the poorest overall survival. To optimize organ allocation for all patients with end-stage liver disease, a better understanding of poor survival for HCC is necessary.

UR - http://www.scopus.com/inward/record.url?scp=70450230745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450230745&partnerID=8YFLogxK

M3 - Article

VL - 75

SP - 901

EP - 908

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 10

ER -